Livzon Pharmaceutical Group (SZSE:000513) 3-Year Book Growth Rate : 5.90% (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Livzon Pharmaceutical Group 3-Year Book Growth Rate?

Livzon Pharmaceutical Group's Book Value per Share for the quarter that ended in Mar. 2024 was ¥15.76.

During the past 12 months, Livzon Pharmaceutical Group's average Book Value per Share Growth Rate was 3.20% per year. During the past 3 years, the average Book Value per Share Growth Rate was 5.90% per year. During the past 5 years, the average Book Value per Share Growth Rate was 6.40% per year. During the past 10 years, the average Book Value per Share Growth Rate was 14.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Livzon Pharmaceutical Group was 38.10% per year. The lowest was -4.10% per year. And the median was 8.10% per year.

Competitive Comparison of Livzon Pharmaceutical Group's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Livzon Pharmaceutical Group's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Livzon Pharmaceutical Group's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Livzon Pharmaceutical Group's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Livzon Pharmaceutical Group's 3-Year Book Growth Rate falls into.

Livzon Pharmaceutical Group 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Livzon Pharmaceutical Group (SZSE:000513) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Livzon Pharmaceutical Group 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Livzon Pharmaceutical Group (SZSE:000513) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (SZSE:000513) » Definitions » 3-Year Book Growth Rate

Traded in Other Exchanges

01513:Hong Kong LP6:Germany

Address

38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090

Website

https://www.livzon.com.cn

Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Livzon Pharmaceutical Group (SZSE:000513) Headlines

No Headlines